Cellular architecture and IC infiltration can vary throughout the tumor; however, the impact of this on PD-L1 expression levels and, more importantly, the PD-L1 status used in assessing patient suitability for certain treatments, is not fully understood. Here, CD274 is linked to neoplasm.